Global Microbiome Therapeutics Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030
Summary
The human microbiome is the collection of all the microorganisms living in association with the human body. These communities consist of a variety of microorganisms including eukaryotes, archaea, bacteria and viruses. Bacteria in an average human body number ten times more than human cells, for a total of about 1000 more genes than are present in the human genome. Because of their small size, however, microorganisms make up only about 1 to 3 percent of our body mass (that's 2 to 6 pounds of bacteria in a 200-pound adult).
These microbes are generally not harmful to us; in fact they are essential for maintaining health. For example, they produce some vitamins that we do not have the genes to make, break down our food to extract nutrients we need to survive, teach our immune systems how to recognize dangerous invaders and even produce helpful anti-inflammatory compounds that fight off other disease-causing microbes.
An ever-growing number of studies have demonstrated that changes in the composition of our microbiomes correlate with numerous disease states, raising the possibility that manipulation of these communities could be used to treat disease.
According to APO Research, The global Microbiome Therapeutics market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Microbiome Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Microbiome Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Microbiome Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Microbiome Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Microbiome Therapeutics include Seres Therapeutics, Assembly Biosciences, Synthetic Biologics, Interxon, PureTech, Synlogic, Enterome BioScience, 4D Pharma and Second Genome, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Microbiome Therapeutics, market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Microbiome Therapeutics, also provides the revenue of main regions and countries. Of the upcoming market potential for Microbiome Therapeutics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Microbiome Therapeutics revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Microbiome Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Microbiome Therapeutics revenue, projected growth trends, production technology, application and end-user industry.
Microbiome Therapeutics segment by Company
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Microbiome Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Microbiome Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Microbiome Therapeutics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Microbiome Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Microbiome Therapeutics industry.
Chapter 3: Detailed analysis of Microbiome Therapeutics companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Microbiome Therapeuticsrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: MEALA by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
The human microbiome is the collection of all the microorganisms living in association with the human body. These communities consist of a variety of microorganisms including eukaryotes, archaea, bacteria and viruses. Bacteria in an average human body number ten times more than human cells, for a total of about 1000 more genes than are present in the human genome. Because of their small size, however, microorganisms make up only about 1 to 3 percent of our body mass (that's 2 to 6 pounds of bacteria in a 200-pound adult).
These microbes are generally not harmful to us; in fact they are essential for maintaining health. For example, they produce some vitamins that we do not have the genes to make, break down our food to extract nutrients we need to survive, teach our immune systems how to recognize dangerous invaders and even produce helpful anti-inflammatory compounds that fight off other disease-causing microbes.
An ever-growing number of studies have demonstrated that changes in the composition of our microbiomes correlate with numerous disease states, raising the possibility that manipulation of these communities could be used to treat disease.
According to APO Research, The global Microbiome Therapeutics market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Microbiome Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Microbiome Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Microbiome Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Microbiome Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Microbiome Therapeutics include Seres Therapeutics, Assembly Biosciences, Synthetic Biologics, Interxon, PureTech, Synlogic, Enterome BioScience, 4D Pharma and Second Genome, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Microbiome Therapeutics, market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Microbiome Therapeutics, also provides the revenue of main regions and countries. Of the upcoming market potential for Microbiome Therapeutics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Microbiome Therapeutics revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Microbiome Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Microbiome Therapeutics revenue, projected growth trends, production technology, application and end-user industry.
Microbiome Therapeutics segment by Company
- Seres Therapeutics
- Assembly Biosciences
- Synthetic Biologics
- Interxon
- PureTech
- Synlogic
- Enterome BioScience
- 4D Pharma
- Second Genome
- AOBiome
- C3 Jian
- Rebiotix
- MicroBiome Therapeutics LLC
- Metabiomics
- Ritter Pharmaceuticals
- Symberix
- OpenBiome
- Azitra
- Symbiotix Biotherapies
- Osel
- Metabogen
- Upper GIT
- Lower GIT
- C. difficile Infection (CDI)
- Inflammatory Bowel Disease (IBD)
- Orphan Drug
- Immuno-oncology
- Others
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Microbiome Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Microbiome Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Microbiome Therapeutics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Microbiome Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Microbiome Therapeutics industry.
Chapter 3: Detailed analysis of Microbiome Therapeutics companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Microbiome Therapeuticsrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: MEALA by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Market Analysis by Type
1.2.1 Global Microbiome Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Upper GIT
1.2.3 Lower GIT
1.3 Market Analysis by Application
1.3.1 Global Microbiome Therapeutics Market Size Growth Rate by Application: 2019 VS 2023 VS 2030
1.3.2 C. difficile Infection (CDI)
1.3.3 Inflammatory Bowel Disease (IBD)
1.3.4 Orphan Drug
1.3.5 Immuno-oncology
1.3.6 Others
1.4 Global Market Growth Prospects
1.5 Global Microbiome Therapeutics Growth Trends by Region
1.5.1 Global Microbiome Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
1.5.2 Microbiome Therapeutics Market Size by Region (2019-2024)
1.5.3 Microbiome Therapeutics Market Size by Region (2025-2030)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
1.8 Years Considered
2 GLOBAL MICROBIOME THERAPEUTICS MARKET DYNAMICS
2.1 Microbiome Therapeutics Industry Trends
2.2 Microbiome Therapeutics Industry Drivers
2.3 Microbiome Therapeutics Industry Opportunities and Challenges
2.4 Microbiome Therapeutics Industry Restraints
3 COMPETITIVE LANDSCAPE BY COMPANY
3.1 Global Microbiome Therapeutics Revenue by Company (2019-2024)
3.2 Global Microbiome Therapeutics Players Revenue Ranking, 2022 VS 2023 VS 2024
3.3 Global Microbiome Therapeutics Key Company Head office and Area Served
3.4 Global Microbiome Therapeutics Company, Product Type & Application
3.5 Global Microbiome Therapeutics Company Commercialization Time
3.6 Market Competitive Analysis
3.6.1 Global Microbiome Therapeutics Market CR5 and HHI
3.6.2 Global Top 5 and 10 Microbiome Therapeutics Players Market Share by Revenue in 2023
3.6.3 2023 Microbiome Therapeutics Tier 1, Tier 2, and Tier
4 MICROBIOME THERAPEUTICS MARKET BY TYPE
4.1 Global Microbiome Therapeutics Market Size by Type (2019 VS 2023 VS 2030)
4.2 Global Microbiome Therapeutics Market Size by Type (2019-2030)
4.3 Global Microbiome Therapeutics Market Size Share by Type (2019-2030)
5 MICROBIOME THERAPEUTICS MARKET BY APPLICATION
5.1 Global Microbiome Therapeutics Market Size by Application (2019 VS 2023 VS 2030)
5.2 Global Microbiome Therapeutics Market Size by Application (2019-2030)
5.3 Global Microbiome Therapeutics Market Size Share by Application (2019-2030)
6 COMPANY PROFILES
6.1 Seres Therapeutics
6.1.1 Seres Therapeutics Comapny Information
6.1.2 Seres Therapeutics Business Overview
6.1.3 Seres Therapeutics Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.1.4 Seres Therapeutics Microbiome Therapeutics Product Portfolio
6.1.5 Seres Therapeutics Recent Developments
6.2 Assembly Biosciences
6.2.1 Assembly Biosciences Comapny Information
6.2.2 Assembly Biosciences Business Overview
6.2.3 Assembly Biosciences Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.2.4 Assembly Biosciences Microbiome Therapeutics Product Portfolio
6.2.5 Assembly Biosciences Recent Developments
6.3 Synthetic Biologics
6.3.1 Synthetic Biologics Comapny Information
6.3.2 Synthetic Biologics Business Overview
6.3.3 Synthetic Biologics Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.3.4 Synthetic Biologics Microbiome Therapeutics Product Portfolio
6.3.5 Synthetic Biologics Recent Developments
6.4 Interxon
6.4.1 Interxon Comapny Information
6.4.2 Interxon Business Overview
6.4.3 Interxon Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.4.4 Interxon Microbiome Therapeutics Product Portfolio
6.4.5 Interxon Recent Developments
6.5 PureTech
6.5.1 PureTech Comapny Information
6.5.2 PureTech Business Overview
6.5.3 PureTech Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.5.4 PureTech Microbiome Therapeutics Product Portfolio
6.5.5 PureTech Recent Developments
6.6 Synlogic
6.6.1 Synlogic Comapny Information
6.6.2 Synlogic Business Overview
6.6.3 Synlogic Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.6.4 Synlogic Microbiome Therapeutics Product Portfolio
6.6.5 Synlogic Recent Developments
6.7 Enterome BioScience
6.7.1 Enterome BioScience Comapny Information
6.7.2 Enterome BioScience Business Overview
6.7.3 Enterome BioScience Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.7.4 Enterome BioScience Microbiome Therapeutics Product Portfolio
6.7.5 Enterome BioScience Recent Developments
6.8 4D Pharma
6.8.1 4D Pharma Comapny Information
6.8.2 4D Pharma Business Overview
6.8.3 4D Pharma Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.8.4 4D Pharma Microbiome Therapeutics Product Portfolio
6.8.5 4D Pharma Recent Developments
6.9 Second Genome
6.9.1 Second Genome Comapny Information
6.9.2 Second Genome Business Overview
6.9.3 Second Genome Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.9.4 Second Genome Microbiome Therapeutics Product Portfolio
6.9.5 Second Genome Recent Developments
6.10 AOBiome
6.10.1 AOBiome Comapny Information
6.10.2 AOBiome Business Overview
6.10.3 AOBiome Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.10.4 AOBiome Microbiome Therapeutics Product Portfolio
6.10.5 AOBiome Recent Developments
6.11 C3 Jian
6.11.1 C3 Jian Comapny Information
6.11.2 C3 Jian Business Overview
6.11.3 C3 Jian Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.11.4 C3 Jian Microbiome Therapeutics Product Portfolio
6.11.5 C3 Jian Recent Developments
6.12 Rebiotix
6.12.1 Rebiotix Comapny Information
6.12.2 Rebiotix Business Overview
6.12.3 Rebiotix Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.12.4 Rebiotix Microbiome Therapeutics Product Portfolio
6.12.5 Rebiotix Recent Developments
6.13 MicroBiome Therapeutics LLC
6.13.1 MicroBiome Therapeutics LLC Comapny Information
6.13.2 MicroBiome Therapeutics LLC Business Overview
6.13.3 MicroBiome Therapeutics LLC Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.13.4 MicroBiome Therapeutics LLC Microbiome Therapeutics Product Portfolio
6.13.5 MicroBiome Therapeutics LLC Recent Developments
6.14 Metabiomics
6.14.1 Metabiomics Comapny Information
6.14.2 Metabiomics Business Overview
6.14.3 Metabiomics Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.14.4 Metabiomics Microbiome Therapeutics Product Portfolio
6.14.5 Metabiomics Recent Developments
6.15 Ritter Pharmaceuticals
6.15.1 Ritter Pharmaceuticals Comapny Information
6.15.2 Ritter Pharmaceuticals Business Overview
6.15.3 Ritter Pharmaceuticals Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.15.4 Ritter Pharmaceuticals Microbiome Therapeutics Product Portfolio
6.15.5 Ritter Pharmaceuticals Recent Developments
6.16 Symberix
6.16.1 Symberix Comapny Information
6.16.2 Symberix Business Overview
6.16.3 Symberix Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.16.4 Symberix Microbiome Therapeutics Product Portfolio
6.16.5 Symberix Recent Developments
6.17 OpenBiome
6.17.1 OpenBiome Comapny Information
6.17.2 OpenBiome Business Overview
6.17.3 OpenBiome Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.17.4 OpenBiome Microbiome Therapeutics Product Portfolio
6.17.5 OpenBiome Recent Developments
6.18 Azitra
6.18.1 Azitra Comapny Information
6.18.2 Azitra Business Overview
6.18.3 Azitra Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.18.4 Azitra Microbiome Therapeutics Product Portfolio
6.18.5 Azitra Recent Developments
6.19 Symbiotix Biotherapies
6.19.1 Symbiotix Biotherapies Comapny Information
6.19.2 Symbiotix Biotherapies Business Overview
6.19.3 Symbiotix Biotherapies Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.19.4 Symbiotix Biotherapies Microbiome Therapeutics Product Portfolio
6.19.5 Symbiotix Biotherapies Recent Developments
6.20 Osel
6.20.1 Osel Comapny Information
6.20.2 Osel Business Overview
6.20.3 Osel Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.20.4 Osel Microbiome Therapeutics Product Portfolio
6.20.5 Osel Recent Developments
6.21 Metabogen
6.21.1 Metabogen Comapny Information
6.21.2 Metabogen Business Overview
6.21.3 Metabogen Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.21.4 Metabogen Microbiome Therapeutics Product Portfolio
6.21.5 Metabogen Recent Developments
7 NORTH AMERICA
7.1 North America Microbiome Therapeutics Market Size (2019-2030)
7.2 North America Microbiome Therapeutics Market Size by Type
7.2.1 North America Microbiome Therapeutics Market Size by Type (2019-2024)
7.2.2 North America Microbiome Therapeutics Market Size by Type (2025-2030)
7.2.3 North America Microbiome Therapeutics Market Share by Type (2019-2030)
7.3 North America Microbiome Therapeutics Market Size by Application
7.3.1 North America Microbiome Therapeutics Market Size by Application (2019-2024)
7.3.2 North America Microbiome Therapeutics Market Size by Application (2025-2030)
7.3.3 North America Microbiome Therapeutics Market Share by Application (2019-2030)
7.4 North America Microbiome Therapeutics Market Size by Country
7.4.1 North America Microbiome Therapeutics Market Size by Country (2019 VS 2023 VS 2030)
7.4.2 North America Microbiome Therapeutics Market Size by Country (2019-2024)
7.4.3 North America Microbiome Therapeutics Market Size by Country (2025-2030)
7.4.4 North America Microbiome Therapeutics Market Share by Country (2019-2030)
7.4.5 United States
7.4.6 Canada
8 EUROPE
8.1 Europe Microbiome Therapeutics Market Size (2019-2030)
8.2 Europe Microbiome Therapeutics Market Size by Type
8.2.1 Europe Microbiome Therapeutics Market Size by Type (2019-2024)
8.2.2 Europe Microbiome Therapeutics Market Size by Type (2025-2030)
8.2.3 Europe Microbiome Therapeutics Market Share by Type (2019-2030)
8.3 Europe Microbiome Therapeutics Market Size by Application
8.3.1 Europe Microbiome Therapeutics Market Size by Application (2019-2024)
8.3.2 Europe Microbiome Therapeutics Market Size by Application (2025-2030)
8.3.3 Europe Microbiome Therapeutics Market Share by Application (2019-2030)
8.4 Europe Microbiome Therapeutics Market Size by Country
8.4.1 Europe Microbiome Therapeutics Market Size by Country (2019 VS 2023 VS 2030)
8.4.2 Europe Microbiome Therapeutics Market Size by Country (2019-2024)
8.4.3 Europe Microbiome Therapeutics Market Size by Country (2025-2030)
8.4.4 Europe Microbiome Therapeutics Market Share by Country (2019-2030)
8.4.5 Germany
8.4.6 France
8.4.7 U.K.
8.4.8 Italy
8.4.9 Russia
8.4.10 Nordic Countries
9 CHINA
9.1 China Microbiome Therapeutics Market Size (2019-2030)
9.2 China Microbiome Therapeutics Market Size by Type
9.2.1 China Microbiome Therapeutics Market Size by Type (2019-2024)
9.2.2 China Microbiome Therapeutics Market Size by Type (2025-2030)
9.2.3 China Microbiome Therapeutics Market Share by Type (2019-2030)
9.3 China Microbiome Therapeutics Market Size by Application
9.3.1 China Microbiome Therapeutics Market Size by Application (2019-2024)
9.3.2 China Microbiome Therapeutics Market Size by Application (2025-2030)
9.3.3 China Microbiome Therapeutics Market Share by Application (2019-2030)
10 ASIA
10.1 Asia Microbiome Therapeutics Market Size (2019-2030)
10.2 Asia Microbiome Therapeutics Market Size by Type
10.2.1 Asia Microbiome Therapeutics Market Size by Type (2019-2024)
10.2.2 Asia Microbiome Therapeutics Market Size by Type (2025-2030)
10.2.3 Asia Microbiome Therapeutics Market Share by Type (2019-2030)
10.3 Asia Microbiome Therapeutics Market Size by Application
10.3.1 Asia Microbiome Therapeutics Market Size by Application (2019-2024)
10.3.2 Asia Microbiome Therapeutics Market Size by Application (2025-2030)
10.3.3 Asia Microbiome Therapeutics Market Share by Application (2019-2030)
10.4 Asia Microbiome Therapeutics Market Size by Country
10.4.1 Asia Microbiome Therapeutics Market Size by Country (2019 VS 2023 VS 2030)
10.4.2 Asia Microbiome Therapeutics Market Size by Country (2019-2024)
10.4.3 Asia Microbiome Therapeutics Market Size by Country (2025-2030)
10.4.4 Asia Microbiome Therapeutics Market Share by Country (2019-2030)
10.4.5 Japan
10.4.6 South Korea
10.4.7 China Taiwan
10.4.8 Southeast Asia
10.4.9 India
10.4.10 Australia
11 MEALA
11.1 MEALA Microbiome Therapeutics Market Size (2019-2030)
11.2 MEALA Microbiome Therapeutics Market Size by Type
11.2.1 MEALA Microbiome Therapeutics Market Size by Type (2019-2024)
11.2.2 MEALA Microbiome Therapeutics Market Size by Type (2025-2030)
11.2.3 MEALA Microbiome Therapeutics Market Share by Type (2019-2030)
11.3 MEALA Microbiome Therapeutics Market Size by Application
11.3.1 MEALA Microbiome Therapeutics Market Size by Application (2019-2024)
11.3.2 MEALA Microbiome Therapeutics Market Size by Application (2025-2030)
11.3.3 MEALA Microbiome Therapeutics Market Share by Application (2019-2030)
11.4 MEALA Microbiome Therapeutics Market Size by Country
11.4.1 MEALA Microbiome Therapeutics Market Size by Country (2019 VS 2023 VS 2030)
11.4.2 MEALA Microbiome Therapeutics Market Size by Country (2019-2024)
11.4.3 MEALA Microbiome Therapeutics Market Size by Country (2025-2030)
11.4.4 MEALA Microbiome Therapeutics Market Share by Country (2019-2030)
11.4.5 Brazil
11.4.6 Mexico
11.4.7 Turkey
11.4.8 Israel
11.4.9 GCC Countries
12 CONCLUDING INSIGHTS
13 APPENDIX
13.1 Reasons for Doing This Study
13.2 Research Methodology
13.3 Research Process
13.4 Authors List of This Report
13.5 Data Source
13.5.1 Secondary Sources
13.5.2 Primary Sources
13.6 Disclaimer
1.1 Product Definition
1.2 Market Analysis by Type
1.2.1 Global Microbiome Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Upper GIT
1.2.3 Lower GIT
1.3 Market Analysis by Application
1.3.1 Global Microbiome Therapeutics Market Size Growth Rate by Application: 2019 VS 2023 VS 2030
1.3.2 C. difficile Infection (CDI)
1.3.3 Inflammatory Bowel Disease (IBD)
1.3.4 Orphan Drug
1.3.5 Immuno-oncology
1.3.6 Others
1.4 Global Market Growth Prospects
1.5 Global Microbiome Therapeutics Growth Trends by Region
1.5.1 Global Microbiome Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
1.5.2 Microbiome Therapeutics Market Size by Region (2019-2024)
1.5.3 Microbiome Therapeutics Market Size by Region (2025-2030)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
1.8 Years Considered
2 GLOBAL MICROBIOME THERAPEUTICS MARKET DYNAMICS
2.1 Microbiome Therapeutics Industry Trends
2.2 Microbiome Therapeutics Industry Drivers
2.3 Microbiome Therapeutics Industry Opportunities and Challenges
2.4 Microbiome Therapeutics Industry Restraints
3 COMPETITIVE LANDSCAPE BY COMPANY
3.1 Global Microbiome Therapeutics Revenue by Company (2019-2024)
3.2 Global Microbiome Therapeutics Players Revenue Ranking, 2022 VS 2023 VS 2024
3.3 Global Microbiome Therapeutics Key Company Head office and Area Served
3.4 Global Microbiome Therapeutics Company, Product Type & Application
3.5 Global Microbiome Therapeutics Company Commercialization Time
3.6 Market Competitive Analysis
3.6.1 Global Microbiome Therapeutics Market CR5 and HHI
3.6.2 Global Top 5 and 10 Microbiome Therapeutics Players Market Share by Revenue in 2023
3.6.3 2023 Microbiome Therapeutics Tier 1, Tier 2, and Tier
4 MICROBIOME THERAPEUTICS MARKET BY TYPE
4.1 Global Microbiome Therapeutics Market Size by Type (2019 VS 2023 VS 2030)
4.2 Global Microbiome Therapeutics Market Size by Type (2019-2030)
4.3 Global Microbiome Therapeutics Market Size Share by Type (2019-2030)
5 MICROBIOME THERAPEUTICS MARKET BY APPLICATION
5.1 Global Microbiome Therapeutics Market Size by Application (2019 VS 2023 VS 2030)
5.2 Global Microbiome Therapeutics Market Size by Application (2019-2030)
5.3 Global Microbiome Therapeutics Market Size Share by Application (2019-2030)
6 COMPANY PROFILES
6.1 Seres Therapeutics
6.1.1 Seres Therapeutics Comapny Information
6.1.2 Seres Therapeutics Business Overview
6.1.3 Seres Therapeutics Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.1.4 Seres Therapeutics Microbiome Therapeutics Product Portfolio
6.1.5 Seres Therapeutics Recent Developments
6.2 Assembly Biosciences
6.2.1 Assembly Biosciences Comapny Information
6.2.2 Assembly Biosciences Business Overview
6.2.3 Assembly Biosciences Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.2.4 Assembly Biosciences Microbiome Therapeutics Product Portfolio
6.2.5 Assembly Biosciences Recent Developments
6.3 Synthetic Biologics
6.3.1 Synthetic Biologics Comapny Information
6.3.2 Synthetic Biologics Business Overview
6.3.3 Synthetic Biologics Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.3.4 Synthetic Biologics Microbiome Therapeutics Product Portfolio
6.3.5 Synthetic Biologics Recent Developments
6.4 Interxon
6.4.1 Interxon Comapny Information
6.4.2 Interxon Business Overview
6.4.3 Interxon Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.4.4 Interxon Microbiome Therapeutics Product Portfolio
6.4.5 Interxon Recent Developments
6.5 PureTech
6.5.1 PureTech Comapny Information
6.5.2 PureTech Business Overview
6.5.3 PureTech Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.5.4 PureTech Microbiome Therapeutics Product Portfolio
6.5.5 PureTech Recent Developments
6.6 Synlogic
6.6.1 Synlogic Comapny Information
6.6.2 Synlogic Business Overview
6.6.3 Synlogic Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.6.4 Synlogic Microbiome Therapeutics Product Portfolio
6.6.5 Synlogic Recent Developments
6.7 Enterome BioScience
6.7.1 Enterome BioScience Comapny Information
6.7.2 Enterome BioScience Business Overview
6.7.3 Enterome BioScience Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.7.4 Enterome BioScience Microbiome Therapeutics Product Portfolio
6.7.5 Enterome BioScience Recent Developments
6.8 4D Pharma
6.8.1 4D Pharma Comapny Information
6.8.2 4D Pharma Business Overview
6.8.3 4D Pharma Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.8.4 4D Pharma Microbiome Therapeutics Product Portfolio
6.8.5 4D Pharma Recent Developments
6.9 Second Genome
6.9.1 Second Genome Comapny Information
6.9.2 Second Genome Business Overview
6.9.3 Second Genome Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.9.4 Second Genome Microbiome Therapeutics Product Portfolio
6.9.5 Second Genome Recent Developments
6.10 AOBiome
6.10.1 AOBiome Comapny Information
6.10.2 AOBiome Business Overview
6.10.3 AOBiome Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.10.4 AOBiome Microbiome Therapeutics Product Portfolio
6.10.5 AOBiome Recent Developments
6.11 C3 Jian
6.11.1 C3 Jian Comapny Information
6.11.2 C3 Jian Business Overview
6.11.3 C3 Jian Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.11.4 C3 Jian Microbiome Therapeutics Product Portfolio
6.11.5 C3 Jian Recent Developments
6.12 Rebiotix
6.12.1 Rebiotix Comapny Information
6.12.2 Rebiotix Business Overview
6.12.3 Rebiotix Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.12.4 Rebiotix Microbiome Therapeutics Product Portfolio
6.12.5 Rebiotix Recent Developments
6.13 MicroBiome Therapeutics LLC
6.13.1 MicroBiome Therapeutics LLC Comapny Information
6.13.2 MicroBiome Therapeutics LLC Business Overview
6.13.3 MicroBiome Therapeutics LLC Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.13.4 MicroBiome Therapeutics LLC Microbiome Therapeutics Product Portfolio
6.13.5 MicroBiome Therapeutics LLC Recent Developments
6.14 Metabiomics
6.14.1 Metabiomics Comapny Information
6.14.2 Metabiomics Business Overview
6.14.3 Metabiomics Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.14.4 Metabiomics Microbiome Therapeutics Product Portfolio
6.14.5 Metabiomics Recent Developments
6.15 Ritter Pharmaceuticals
6.15.1 Ritter Pharmaceuticals Comapny Information
6.15.2 Ritter Pharmaceuticals Business Overview
6.15.3 Ritter Pharmaceuticals Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.15.4 Ritter Pharmaceuticals Microbiome Therapeutics Product Portfolio
6.15.5 Ritter Pharmaceuticals Recent Developments
6.16 Symberix
6.16.1 Symberix Comapny Information
6.16.2 Symberix Business Overview
6.16.3 Symberix Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.16.4 Symberix Microbiome Therapeutics Product Portfolio
6.16.5 Symberix Recent Developments
6.17 OpenBiome
6.17.1 OpenBiome Comapny Information
6.17.2 OpenBiome Business Overview
6.17.3 OpenBiome Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.17.4 OpenBiome Microbiome Therapeutics Product Portfolio
6.17.5 OpenBiome Recent Developments
6.18 Azitra
6.18.1 Azitra Comapny Information
6.18.2 Azitra Business Overview
6.18.3 Azitra Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.18.4 Azitra Microbiome Therapeutics Product Portfolio
6.18.5 Azitra Recent Developments
6.19 Symbiotix Biotherapies
6.19.1 Symbiotix Biotherapies Comapny Information
6.19.2 Symbiotix Biotherapies Business Overview
6.19.3 Symbiotix Biotherapies Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.19.4 Symbiotix Biotherapies Microbiome Therapeutics Product Portfolio
6.19.5 Symbiotix Biotherapies Recent Developments
6.20 Osel
6.20.1 Osel Comapny Information
6.20.2 Osel Business Overview
6.20.3 Osel Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.20.4 Osel Microbiome Therapeutics Product Portfolio
6.20.5 Osel Recent Developments
6.21 Metabogen
6.21.1 Metabogen Comapny Information
6.21.2 Metabogen Business Overview
6.21.3 Metabogen Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.21.4 Metabogen Microbiome Therapeutics Product Portfolio
6.21.5 Metabogen Recent Developments
7 NORTH AMERICA
7.1 North America Microbiome Therapeutics Market Size (2019-2030)
7.2 North America Microbiome Therapeutics Market Size by Type
7.2.1 North America Microbiome Therapeutics Market Size by Type (2019-2024)
7.2.2 North America Microbiome Therapeutics Market Size by Type (2025-2030)
7.2.3 North America Microbiome Therapeutics Market Share by Type (2019-2030)
7.3 North America Microbiome Therapeutics Market Size by Application
7.3.1 North America Microbiome Therapeutics Market Size by Application (2019-2024)
7.3.2 North America Microbiome Therapeutics Market Size by Application (2025-2030)
7.3.3 North America Microbiome Therapeutics Market Share by Application (2019-2030)
7.4 North America Microbiome Therapeutics Market Size by Country
7.4.1 North America Microbiome Therapeutics Market Size by Country (2019 VS 2023 VS 2030)
7.4.2 North America Microbiome Therapeutics Market Size by Country (2019-2024)
7.4.3 North America Microbiome Therapeutics Market Size by Country (2025-2030)
7.4.4 North America Microbiome Therapeutics Market Share by Country (2019-2030)
7.4.5 United States
7.4.6 Canada
8 EUROPE
8.1 Europe Microbiome Therapeutics Market Size (2019-2030)
8.2 Europe Microbiome Therapeutics Market Size by Type
8.2.1 Europe Microbiome Therapeutics Market Size by Type (2019-2024)
8.2.2 Europe Microbiome Therapeutics Market Size by Type (2025-2030)
8.2.3 Europe Microbiome Therapeutics Market Share by Type (2019-2030)
8.3 Europe Microbiome Therapeutics Market Size by Application
8.3.1 Europe Microbiome Therapeutics Market Size by Application (2019-2024)
8.3.2 Europe Microbiome Therapeutics Market Size by Application (2025-2030)
8.3.3 Europe Microbiome Therapeutics Market Share by Application (2019-2030)
8.4 Europe Microbiome Therapeutics Market Size by Country
8.4.1 Europe Microbiome Therapeutics Market Size by Country (2019 VS 2023 VS 2030)
8.4.2 Europe Microbiome Therapeutics Market Size by Country (2019-2024)
8.4.3 Europe Microbiome Therapeutics Market Size by Country (2025-2030)
8.4.4 Europe Microbiome Therapeutics Market Share by Country (2019-2030)
8.4.5 Germany
8.4.6 France
8.4.7 U.K.
8.4.8 Italy
8.4.9 Russia
8.4.10 Nordic Countries
9 CHINA
9.1 China Microbiome Therapeutics Market Size (2019-2030)
9.2 China Microbiome Therapeutics Market Size by Type
9.2.1 China Microbiome Therapeutics Market Size by Type (2019-2024)
9.2.2 China Microbiome Therapeutics Market Size by Type (2025-2030)
9.2.3 China Microbiome Therapeutics Market Share by Type (2019-2030)
9.3 China Microbiome Therapeutics Market Size by Application
9.3.1 China Microbiome Therapeutics Market Size by Application (2019-2024)
9.3.2 China Microbiome Therapeutics Market Size by Application (2025-2030)
9.3.3 China Microbiome Therapeutics Market Share by Application (2019-2030)
10 ASIA
10.1 Asia Microbiome Therapeutics Market Size (2019-2030)
10.2 Asia Microbiome Therapeutics Market Size by Type
10.2.1 Asia Microbiome Therapeutics Market Size by Type (2019-2024)
10.2.2 Asia Microbiome Therapeutics Market Size by Type (2025-2030)
10.2.3 Asia Microbiome Therapeutics Market Share by Type (2019-2030)
10.3 Asia Microbiome Therapeutics Market Size by Application
10.3.1 Asia Microbiome Therapeutics Market Size by Application (2019-2024)
10.3.2 Asia Microbiome Therapeutics Market Size by Application (2025-2030)
10.3.3 Asia Microbiome Therapeutics Market Share by Application (2019-2030)
10.4 Asia Microbiome Therapeutics Market Size by Country
10.4.1 Asia Microbiome Therapeutics Market Size by Country (2019 VS 2023 VS 2030)
10.4.2 Asia Microbiome Therapeutics Market Size by Country (2019-2024)
10.4.3 Asia Microbiome Therapeutics Market Size by Country (2025-2030)
10.4.4 Asia Microbiome Therapeutics Market Share by Country (2019-2030)
10.4.5 Japan
10.4.6 South Korea
10.4.7 China Taiwan
10.4.8 Southeast Asia
10.4.9 India
10.4.10 Australia
11 MEALA
11.1 MEALA Microbiome Therapeutics Market Size (2019-2030)
11.2 MEALA Microbiome Therapeutics Market Size by Type
11.2.1 MEALA Microbiome Therapeutics Market Size by Type (2019-2024)
11.2.2 MEALA Microbiome Therapeutics Market Size by Type (2025-2030)
11.2.3 MEALA Microbiome Therapeutics Market Share by Type (2019-2030)
11.3 MEALA Microbiome Therapeutics Market Size by Application
11.3.1 MEALA Microbiome Therapeutics Market Size by Application (2019-2024)
11.3.2 MEALA Microbiome Therapeutics Market Size by Application (2025-2030)
11.3.3 MEALA Microbiome Therapeutics Market Share by Application (2019-2030)
11.4 MEALA Microbiome Therapeutics Market Size by Country
11.4.1 MEALA Microbiome Therapeutics Market Size by Country (2019 VS 2023 VS 2030)
11.4.2 MEALA Microbiome Therapeutics Market Size by Country (2019-2024)
11.4.3 MEALA Microbiome Therapeutics Market Size by Country (2025-2030)
11.4.4 MEALA Microbiome Therapeutics Market Share by Country (2019-2030)
11.4.5 Brazil
11.4.6 Mexico
11.4.7 Turkey
11.4.8 Israel
11.4.9 GCC Countries
12 CONCLUDING INSIGHTS
13 APPENDIX
13.1 Reasons for Doing This Study
13.2 Research Methodology
13.3 Research Process
13.4 Authors List of This Report
13.5 Data Source
13.5.1 Secondary Sources
13.5.2 Primary Sources
13.6 Disclaimer
LIST OF TABLES
Table 1. Global Microbiome Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Upper GIT
Table 3. Key Players of Lower GIT
Table 5. Global Microbiome Therapeutics Market Size Growth Rate by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Key Players of C. difficile Infection (CDI)
Table 7. Key Players of Inflammatory Bowel Disease (IBD)
Table 8. Key Players of Orphan Drug
Table 9. Key Players of Immuno-oncology
Table 10. Key Players of Others
Table 11. Global Microbiome Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 12. Global Microbiome Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 13. Global Microbiome Therapeutics Market Share by Region (2019-2024)
Table 14. Global Microbiome Therapeutics Market Size by Region (2025-2030) & (US$ Million)
Table 15. Global Microbiome Therapeutics Market Share by Region (2025-2030)
Table 16. Microbiome Therapeutics Industry Trends
Table 17. Microbiome Therapeutics Industry Drivers
Table 18. Microbiome Therapeutics Industry Opportunities and Challenges
Table 19. Microbiome Therapeutics Industry Restraints
Table 20. Global Microbiome Therapeutics Revenue by Company (US$ Million) & (2019-2024)
Table 21. Global Microbiome Therapeutics Revenue Market Share by Company (2019-2024)
Table 22. Global Microbiome Therapeutics Players Revenue Ranking, 2022 VS 2023 VS 2024
Table 23. Global Microbiome Therapeutics Key Company Head office and Area Served
Table 24. Global Microbiome Therapeutics Company, Product Type & Application
Table 25. Global Microbiome Therapeutics Company Commercialization Time
Table 26. Global Company Market Concentration Ratio (CR5 and HHI)
Table 27. Global Microbiome Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 28. Global Microbiome Therapeutics Market Size by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Microbiome Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 30. Global Microbiome Therapeutics Market Size by Type (2025-2030) & (US$ Million)
Table 31. Global Microbiome Therapeutics Revenue Market Share by Type (2019-2024)
Table 32. Global Microbiome Therapeutics Revenue Market Share by Type (2025-2030)
Table 33. Global Microbiome Therapeutics Market Size by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 34. Global Microbiome Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 35. Global Microbiome Therapeutics Market Size by Application (2025-2030) & (US$ Million)
Table 36. Global Microbiome Therapeutics Revenue Market Share by Application (2019-2024)
Table 37. Global Microbiome Therapeutics Revenue Market Share by Application (2025-2030)
Table 38. Seres Therapeutics Business Overview
Table 39. Seres Therapeutics Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 40. Seres Therapeutics Microbiome Therapeutics Product Portfolio
Table 41. Seres Therapeutics Recent Development
Table 42. Assembly Biosciences Company Information
Table 43. Assembly Biosciences Business Overview
Table 44. Assembly Biosciences Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 45. Assembly Biosciences Microbiome Therapeutics Product Portfolio
Table 46. Assembly Biosciences Recent Development
Table 47. Synthetic Biologics Company Information
Table 48. Synthetic Biologics Business Overview
Table 49. Synthetic Biologics Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 50. Synthetic Biologics Microbiome Therapeutics Product Portfolio
Table 51. Synthetic Biologics Recent Development
Table 52. Interxon Company Information
Table 53. Interxon Business Overview
Table 54. Interxon Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 55. Interxon Microbiome Therapeutics Product Portfolio
Table 56. Interxon Recent Development
Table 57. PureTech Company Information
Table 58. PureTech Business Overview
Table 59. PureTech Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 60. PureTech Microbiome Therapeutics Product Portfolio
Table 61. PureTech Recent Development
Table 62. Synlogic Company Information
Table 63. Synlogic Business Overview
Table 64. Synlogic Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 65. Synlogic Microbiome Therapeutics Product Portfolio
Table 66. Synlogic Recent Development
Table 67. Enterome BioScience Company Information
Table 68. Enterome BioScience Business Overview
Table 69. Enterome BioScience Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 70. Enterome BioScience Microbiome Therapeutics Product Portfolio
Table 71. Enterome BioScience Recent Development
Table 72. 4D Pharma Company Information
Table 73. 4D Pharma Business Overview
Table 74. 4D Pharma Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 75. 4D Pharma Microbiome Therapeutics Product Portfolio
Table 76. 4D Pharma Recent Development
Table 77. Second Genome Company Information
Table 78. Second Genome Business Overview
Table 79. Second Genome Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 80. Second Genome Microbiome Therapeutics Product Portfolio
Table 81. Second Genome Recent Development
Table 82. AOBiome Company Information
Table 83. AOBiome Business Overview
Table 84. AOBiome Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 85. AOBiome Microbiome Therapeutics Product Portfolio
Table 86. AOBiome Recent Development
Table 87. C3 Jian Company Information
Table 88. C3 Jian Business Overview
Table 89. C3 Jian Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 90. C3 Jian Microbiome Therapeutics Product Portfolio
Table 91. C3 Jian Recent Development
Table 92. Rebiotix Company Information
Table 93. Rebiotix Business Overview
Table 94. Rebiotix Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 95. Rebiotix Microbiome Therapeutics Product Portfolio
Table 96. Rebiotix Recent Development
Table 97. MicroBiome Therapeutics LLC Company Information
Table 98. MicroBiome Therapeutics LLC Business Overview
Table 99. MicroBiome Therapeutics LLC Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 100. MicroBiome Therapeutics LLC Microbiome Therapeutics Product Portfolio
Table 101. MicroBiome Therapeutics LLC Recent Development
Table 102. Metabiomics Company Information
Table 103. Metabiomics Business Overview
Table 104. Metabiomics Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 105. Metabiomics Microbiome Therapeutics Product Portfolio
Table 106. Metabiomics Recent Development
Table 107. Ritter Pharmaceuticals Company Information
Table 108. Ritter Pharmaceuticals Business Overview
Table 109. Ritter Pharmaceuticals Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 110. Ritter Pharmaceuticals Microbiome Therapeutics Product Portfolio
Table 111. Ritter Pharmaceuticals Recent Development
Table 112. Symberix Company Information
Table 113. Symberix Business Overview
Table 114. Symberix Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 115. Symberix Microbiome Therapeutics Product Portfolio
Table 116. Symberix Recent Development
Table 117. OpenBiome Company Information
Table 118. OpenBiome Business Overview
Table 119. OpenBiome Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 120. OpenBiome Microbiome Therapeutics Product Portfolio
Table 121. OpenBiome Recent Development
Table 122. Azitra Company Information
Table 123. Azitra Business Overview
Table 124. Azitra Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 125. Azitra Microbiome Therapeutics Product Portfolio
Table 126. Azitra Recent Development
Table 127. Symbiotix Biotherapies Company Information
Table 128. Symbiotix Biotherapies Business Overview
Table 129. Symbiotix Biotherapies Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 130. Symbiotix Biotherapies Microbiome Therapeutics Product Portfolio
Table 131. Symbiotix Biotherapies Recent Development
Table 132. Osel Company Information
Table 133. Osel Business Overview
Table 134. Osel Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 135. Osel Microbiome Therapeutics Product Portfolio
Table 136. Osel Recent Development
Table 137. Metabogen Company Information
Table 138. Metabogen Business Overview
Table 139. Metabogen Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 140. Metabogen Microbiome Therapeutics Product Portfolio
Table 141. Metabogen Recent Development
Table 142. North America Microbiome Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 143. North America Microbiome Therapeutics Market Size by Type (2025-2030) & (US$ Million)
Table 144. North America Microbiome Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 145. North America Microbiome Therapeutics Market Size by Application (2025-2030) & (US$ Million)
Table 146. North America Microbiome Therapeutics Market Size by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 147. North America Microbiome Therapeutics Market Size by Country (2019-2024)
Table 148. North America Microbiome Therapeutics Market Size by Country (2025-2030)
Table 149. Europe Microbiome Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 150. Europe Microbiome Therapeutics Market Size by Type (2025-2030) & (US$ Million)
Table 151. Europe Microbiome Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 152. Europe Microbiome Therapeutics Market Size by Application (2025-2030) & (US$ Million)
Table 153. Europe Microbiome Therapeutics Market Size by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 154. Europe Microbiome Therapeutics Market Size by Country (2019-2024)
Table 155. Europe Microbiome Therapeutics Market Size by Country (2025-2030)
Table 156. China Microbiome Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 157. China Microbiome Therapeutics Market Size by Type (2025-2030) & (US$ Million)
Table 158. China Microbiome Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 159. China Microbiome Therapeutics Market Size by Application (2025-2030) & (US$ Million)
Table 160. Asia Microbiome Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 161. Asia Microbiome Therapeutics Market Size by Type (2025-2030) & (US$ Million)
Table 162. Asia Microbiome Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 163. Asia Microbiome Therapeutics Market Size by Application (2025-2030) & (US$ Million)
Table 164. Asia Microbiome Therapeutics Market Size by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 165. Asia Microbiome Therapeutics Market Size by Country (2019-2024)
Table 166. Asia Microbiome Therapeutics Market Size by Country (2025-2030)
Table 167. MEALA Microbiome Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 168. MEALA Microbiome Therapeutics Market Size by Type (2025-2030) & (US$ Million)
Table 169. MEALA Microbiome Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 170. MEALA Microbiome Therapeutics Market Size by Application (2025-2030) & (US$ Million)
Table 171. MEALA Microbiome Therapeutics Market Size by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 172. MEALA Microbiome Therapeutics Market Size by Country (2019-2024)
Table 173. MEALA Microbiome Therapeutics Market Size by Country (2025-2030)
Table 174. Research Programs/Design for This Report
Table 175. Authors List of This Report
Table 176. Secondary Sources
Table 177. Primary Sources
Table 1. Global Microbiome Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Upper GIT
Table 3. Key Players of Lower GIT
Table 5. Global Microbiome Therapeutics Market Size Growth Rate by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Key Players of C. difficile Infection (CDI)
Table 7. Key Players of Inflammatory Bowel Disease (IBD)
Table 8. Key Players of Orphan Drug
Table 9. Key Players of Immuno-oncology
Table 10. Key Players of Others
Table 11. Global Microbiome Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 12. Global Microbiome Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 13. Global Microbiome Therapeutics Market Share by Region (2019-2024)
Table 14. Global Microbiome Therapeutics Market Size by Region (2025-2030) & (US$ Million)
Table 15. Global Microbiome Therapeutics Market Share by Region (2025-2030)
Table 16. Microbiome Therapeutics Industry Trends
Table 17. Microbiome Therapeutics Industry Drivers
Table 18. Microbiome Therapeutics Industry Opportunities and Challenges
Table 19. Microbiome Therapeutics Industry Restraints
Table 20. Global Microbiome Therapeutics Revenue by Company (US$ Million) & (2019-2024)
Table 21. Global Microbiome Therapeutics Revenue Market Share by Company (2019-2024)
Table 22. Global Microbiome Therapeutics Players Revenue Ranking, 2022 VS 2023 VS 2024
Table 23. Global Microbiome Therapeutics Key Company Head office and Area Served
Table 24. Global Microbiome Therapeutics Company, Product Type & Application
Table 25. Global Microbiome Therapeutics Company Commercialization Time
Table 26. Global Company Market Concentration Ratio (CR5 and HHI)
Table 27. Global Microbiome Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 28. Global Microbiome Therapeutics Market Size by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Microbiome Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 30. Global Microbiome Therapeutics Market Size by Type (2025-2030) & (US$ Million)
Table 31. Global Microbiome Therapeutics Revenue Market Share by Type (2019-2024)
Table 32. Global Microbiome Therapeutics Revenue Market Share by Type (2025-2030)
Table 33. Global Microbiome Therapeutics Market Size by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 34. Global Microbiome Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 35. Global Microbiome Therapeutics Market Size by Application (2025-2030) & (US$ Million)
Table 36. Global Microbiome Therapeutics Revenue Market Share by Application (2019-2024)
Table 37. Global Microbiome Therapeutics Revenue Market Share by Application (2025-2030)
Table 38. Seres Therapeutics Business Overview
Table 39. Seres Therapeutics Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 40. Seres Therapeutics Microbiome Therapeutics Product Portfolio
Table 41. Seres Therapeutics Recent Development
Table 42. Assembly Biosciences Company Information
Table 43. Assembly Biosciences Business Overview
Table 44. Assembly Biosciences Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 45. Assembly Biosciences Microbiome Therapeutics Product Portfolio
Table 46. Assembly Biosciences Recent Development
Table 47. Synthetic Biologics Company Information
Table 48. Synthetic Biologics Business Overview
Table 49. Synthetic Biologics Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 50. Synthetic Biologics Microbiome Therapeutics Product Portfolio
Table 51. Synthetic Biologics Recent Development
Table 52. Interxon Company Information
Table 53. Interxon Business Overview
Table 54. Interxon Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 55. Interxon Microbiome Therapeutics Product Portfolio
Table 56. Interxon Recent Development
Table 57. PureTech Company Information
Table 58. PureTech Business Overview
Table 59. PureTech Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 60. PureTech Microbiome Therapeutics Product Portfolio
Table 61. PureTech Recent Development
Table 62. Synlogic Company Information
Table 63. Synlogic Business Overview
Table 64. Synlogic Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 65. Synlogic Microbiome Therapeutics Product Portfolio
Table 66. Synlogic Recent Development
Table 67. Enterome BioScience Company Information
Table 68. Enterome BioScience Business Overview
Table 69. Enterome BioScience Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 70. Enterome BioScience Microbiome Therapeutics Product Portfolio
Table 71. Enterome BioScience Recent Development
Table 72. 4D Pharma Company Information
Table 73. 4D Pharma Business Overview
Table 74. 4D Pharma Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 75. 4D Pharma Microbiome Therapeutics Product Portfolio
Table 76. 4D Pharma Recent Development
Table 77. Second Genome Company Information
Table 78. Second Genome Business Overview
Table 79. Second Genome Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 80. Second Genome Microbiome Therapeutics Product Portfolio
Table 81. Second Genome Recent Development
Table 82. AOBiome Company Information
Table 83. AOBiome Business Overview
Table 84. AOBiome Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 85. AOBiome Microbiome Therapeutics Product Portfolio
Table 86. AOBiome Recent Development
Table 87. C3 Jian Company Information
Table 88. C3 Jian Business Overview
Table 89. C3 Jian Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 90. C3 Jian Microbiome Therapeutics Product Portfolio
Table 91. C3 Jian Recent Development
Table 92. Rebiotix Company Information
Table 93. Rebiotix Business Overview
Table 94. Rebiotix Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 95. Rebiotix Microbiome Therapeutics Product Portfolio
Table 96. Rebiotix Recent Development
Table 97. MicroBiome Therapeutics LLC Company Information
Table 98. MicroBiome Therapeutics LLC Business Overview
Table 99. MicroBiome Therapeutics LLC Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 100. MicroBiome Therapeutics LLC Microbiome Therapeutics Product Portfolio
Table 101. MicroBiome Therapeutics LLC Recent Development
Table 102. Metabiomics Company Information
Table 103. Metabiomics Business Overview
Table 104. Metabiomics Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 105. Metabiomics Microbiome Therapeutics Product Portfolio
Table 106. Metabiomics Recent Development
Table 107. Ritter Pharmaceuticals Company Information
Table 108. Ritter Pharmaceuticals Business Overview
Table 109. Ritter Pharmaceuticals Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 110. Ritter Pharmaceuticals Microbiome Therapeutics Product Portfolio
Table 111. Ritter Pharmaceuticals Recent Development
Table 112. Symberix Company Information
Table 113. Symberix Business Overview
Table 114. Symberix Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 115. Symberix Microbiome Therapeutics Product Portfolio
Table 116. Symberix Recent Development
Table 117. OpenBiome Company Information
Table 118. OpenBiome Business Overview
Table 119. OpenBiome Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 120. OpenBiome Microbiome Therapeutics Product Portfolio
Table 121. OpenBiome Recent Development
Table 122. Azitra Company Information
Table 123. Azitra Business Overview
Table 124. Azitra Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 125. Azitra Microbiome Therapeutics Product Portfolio
Table 126. Azitra Recent Development
Table 127. Symbiotix Biotherapies Company Information
Table 128. Symbiotix Biotherapies Business Overview
Table 129. Symbiotix Biotherapies Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 130. Symbiotix Biotherapies Microbiome Therapeutics Product Portfolio
Table 131. Symbiotix Biotherapies Recent Development
Table 132. Osel Company Information
Table 133. Osel Business Overview
Table 134. Osel Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 135. Osel Microbiome Therapeutics Product Portfolio
Table 136. Osel Recent Development
Table 137. Metabogen Company Information
Table 138. Metabogen Business Overview
Table 139. Metabogen Microbiome Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 140. Metabogen Microbiome Therapeutics Product Portfolio
Table 141. Metabogen Recent Development
Table 142. North America Microbiome Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 143. North America Microbiome Therapeutics Market Size by Type (2025-2030) & (US$ Million)
Table 144. North America Microbiome Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 145. North America Microbiome Therapeutics Market Size by Application (2025-2030) & (US$ Million)
Table 146. North America Microbiome Therapeutics Market Size by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 147. North America Microbiome Therapeutics Market Size by Country (2019-2024)
Table 148. North America Microbiome Therapeutics Market Size by Country (2025-2030)
Table 149. Europe Microbiome Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 150. Europe Microbiome Therapeutics Market Size by Type (2025-2030) & (US$ Million)
Table 151. Europe Microbiome Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 152. Europe Microbiome Therapeutics Market Size by Application (2025-2030) & (US$ Million)
Table 153. Europe Microbiome Therapeutics Market Size by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 154. Europe Microbiome Therapeutics Market Size by Country (2019-2024)
Table 155. Europe Microbiome Therapeutics Market Size by Country (2025-2030)
Table 156. China Microbiome Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 157. China Microbiome Therapeutics Market Size by Type (2025-2030) & (US$ Million)
Table 158. China Microbiome Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 159. China Microbiome Therapeutics Market Size by Application (2025-2030) & (US$ Million)
Table 160. Asia Microbiome Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 161. Asia Microbiome Therapeutics Market Size by Type (2025-2030) & (US$ Million)
Table 162. Asia Microbiome Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 163. Asia Microbiome Therapeutics Market Size by Application (2025-2030) & (US$ Million)
Table 164. Asia Microbiome Therapeutics Market Size by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 165. Asia Microbiome Therapeutics Market Size by Country (2019-2024)
Table 166. Asia Microbiome Therapeutics Market Size by Country (2025-2030)
Table 167. MEALA Microbiome Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 168. MEALA Microbiome Therapeutics Market Size by Type (2025-2030) & (US$ Million)
Table 169. MEALA Microbiome Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 170. MEALA Microbiome Therapeutics Market Size by Application (2025-2030) & (US$ Million)
Table 171. MEALA Microbiome Therapeutics Market Size by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 172. MEALA Microbiome Therapeutics Market Size by Country (2019-2024)
Table 173. MEALA Microbiome Therapeutics Market Size by Country (2025-2030)
Table 174. Research Programs/Design for This Report
Table 175. Authors List of This Report
Table 176. Secondary Sources
Table 177. Primary Sources
LIST OF FIGURES
Figure 1. Microbiome Therapeutics Product Picture
Figure 2. Global Microbiome Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Microbiome Therapeutics Market Share by Type: 2023 VS 2030
Figure 4. Upper GIT Picture
Figure 5. Lower GIT Picture
Figure 6. Global Microbiome Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 7. Global Microbiome Therapeutics Market Share by Application: 2023 VS 2030
Figure 8. C. difficile Infection (CDI) Picture
Figure 9. Inflammatory Bowel Disease (IBD) Picture
Figure 10. Orphan Drug Picture
Figure 11. Immuno-oncology Picture
Figure 12. Others Picture
Figure 13. Global Microbiome Therapeutics Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Microbiome Therapeutics Market Size (2019-2030) & (US$ Million)
Figure 15. Global Microbiome Therapeutics Market Share by Region: 2023 VS 2030
Figure 16. Years Considered
Figure 17. Global Microbiome Therapeutics Market Share by Players in 2023
Figure 18. Global Top 5 and 10 Microbiome Therapeutics Players Market Share by Revenue in 2023
Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 20. Global Microbiome Therapeutics Market Size by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 21. Global Microbiome Therapeutics Revenue Market Share by Type (2019-2030)
Figure 22. Global Microbiome Therapeutics Market Size by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 23. Global Microbiome Therapeutics Revenue Market Share by Application (2019-2030)
Figure 24. North America Microbiome Therapeutics Market Size (2019-2030) & (US$ Million)
Figure 25. North America Microbiome Therapeutics Market Share by Type (2019-2030)
Figure 26. North America Microbiome Therapeutics Market Share by Application (2019-2030)
Figure 27. North America Microbiome Therapeutics Market Share by Country (2019-2030)
Figure 28. United States Microbiome Therapeutics Market Size (2019-2030) & (US$ Million)
Figure 29. Canada Microbiome Therapeutics Market Size (2019-2030) & (US$ Million)
Figure 30. Europe Microbiome Therapeutics Market Size (2019-2030) & (US$ Million)
Figure 31. Europe Microbiome Therapeutics Market Share by Type (2019-2030)
Figure 32. Europe Microbiome Therapeutics Market Share by Application (2019-2030)
Figure 33. Europe Microbiome Therapeutics Market Share by Country (2019-2030)
Figure 34. Germany Microbiome Therapeutics Market Size (2019-2030) & (US$ Million)
Figure 35. France Microbiome Therapeutics Market Size (2019-2030) & (US$ Million)
Figure 36. U.K. Microbiome Therapeutics Market Size (2019-2030) & (US$ Million)
Figure 37. Italy Microbiome Therapeutics Market Size (2019-2030) & (US$ Million)
Figure 38. Russia Microbiome Therapeutics Market Size (2019-2030) & (US$ Million)
Figure 39. Nordic Countries Microbiome Therapeutics Market Size (2019-2030) & (US$ Million)
Figure 40. China Microbiome Therapeutics Market Size (2019-2030) & (US$ Million)
Figure 41. China Microbiome Therapeutics Market Share by Type (2019-2030)
Figure 42. China Microbiome Therapeutics Market Share by Application (2019-2030)
Figure 43. Asia Microbiome Therapeutics Market Size (2019-2030) & (US$ Million)
Figure 44. Asia Microbiome Therapeutics Market Share by Type (2019-2030)
Figure 45. Asia Microbiome Therapeutics Market Share by Application (2019-2030)
Figure 46. Asia Microbiome Therapeutics Market Share by Country (2019-2030)
Figure 47. Japan Microbiome Therapeutics Market Size (2019-2030) & (US$ Million)
Figure 48. South Korea Microbiome Therapeutics Market Size (2019-2030) & (US$ Million)
Figure 49. China Taiwan Microbiome Therapeutics Market Size (2019-2030) & (US$ Million)
Figure 50. Southeast Asia Microbiome Therapeutics Market Size (2019-2030) & (US$ Million)
Figure 51. India Microbiome Therapeutics Market Size (2019-2030) & (US$ Million)
Figure 52. Australia Microbiome Therapeutics Market Size (2019-2030) & (US$ Million)
Figure 53. ME
Figure 1. Microbiome Therapeutics Product Picture
Figure 2. Global Microbiome Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Microbiome Therapeutics Market Share by Type: 2023 VS 2030
Figure 4. Upper GIT Picture
Figure 5. Lower GIT Picture
Figure 6. Global Microbiome Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 7. Global Microbiome Therapeutics Market Share by Application: 2023 VS 2030
Figure 8. C. difficile Infection (CDI) Picture
Figure 9. Inflammatory Bowel Disease (IBD) Picture
Figure 10. Orphan Drug Picture
Figure 11. Immuno-oncology Picture
Figure 12. Others Picture
Figure 13. Global Microbiome Therapeutics Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Microbiome Therapeutics Market Size (2019-2030) & (US$ Million)
Figure 15. Global Microbiome Therapeutics Market Share by Region: 2023 VS 2030
Figure 16. Years Considered
Figure 17. Global Microbiome Therapeutics Market Share by Players in 2023
Figure 18. Global Top 5 and 10 Microbiome Therapeutics Players Market Share by Revenue in 2023
Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 20. Global Microbiome Therapeutics Market Size by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 21. Global Microbiome Therapeutics Revenue Market Share by Type (2019-2030)
Figure 22. Global Microbiome Therapeutics Market Size by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 23. Global Microbiome Therapeutics Revenue Market Share by Application (2019-2030)
Figure 24. North America Microbiome Therapeutics Market Size (2019-2030) & (US$ Million)
Figure 25. North America Microbiome Therapeutics Market Share by Type (2019-2030)
Figure 26. North America Microbiome Therapeutics Market Share by Application (2019-2030)
Figure 27. North America Microbiome Therapeutics Market Share by Country (2019-2030)
Figure 28. United States Microbiome Therapeutics Market Size (2019-2030) & (US$ Million)
Figure 29. Canada Microbiome Therapeutics Market Size (2019-2030) & (US$ Million)
Figure 30. Europe Microbiome Therapeutics Market Size (2019-2030) & (US$ Million)
Figure 31. Europe Microbiome Therapeutics Market Share by Type (2019-2030)
Figure 32. Europe Microbiome Therapeutics Market Share by Application (2019-2030)
Figure 33. Europe Microbiome Therapeutics Market Share by Country (2019-2030)
Figure 34. Germany Microbiome Therapeutics Market Size (2019-2030) & (US$ Million)
Figure 35. France Microbiome Therapeutics Market Size (2019-2030) & (US$ Million)
Figure 36. U.K. Microbiome Therapeutics Market Size (2019-2030) & (US$ Million)
Figure 37. Italy Microbiome Therapeutics Market Size (2019-2030) & (US$ Million)
Figure 38. Russia Microbiome Therapeutics Market Size (2019-2030) & (US$ Million)
Figure 39. Nordic Countries Microbiome Therapeutics Market Size (2019-2030) & (US$ Million)
Figure 40. China Microbiome Therapeutics Market Size (2019-2030) & (US$ Million)
Figure 41. China Microbiome Therapeutics Market Share by Type (2019-2030)
Figure 42. China Microbiome Therapeutics Market Share by Application (2019-2030)
Figure 43. Asia Microbiome Therapeutics Market Size (2019-2030) & (US$ Million)
Figure 44. Asia Microbiome Therapeutics Market Share by Type (2019-2030)
Figure 45. Asia Microbiome Therapeutics Market Share by Application (2019-2030)
Figure 46. Asia Microbiome Therapeutics Market Share by Country (2019-2030)
Figure 47. Japan Microbiome Therapeutics Market Size (2019-2030) & (US$ Million)
Figure 48. South Korea Microbiome Therapeutics Market Size (2019-2030) & (US$ Million)
Figure 49. China Taiwan Microbiome Therapeutics Market Size (2019-2030) & (US$ Million)
Figure 50. Southeast Asia Microbiome Therapeutics Market Size (2019-2030) & (US$ Million)
Figure 51. India Microbiome Therapeutics Market Size (2019-2030) & (US$ Million)
Figure 52. Australia Microbiome Therapeutics Market Size (2019-2030) & (US$ Million)
Figure 53. ME
